IDEAS home Printed from https://ideas.repec.org/f/pli751.html
   My authors  Follow this author

Ismo Erkki Olavi Linnosmaa

Personal Details

First Name:Ismo
Middle Name:Erkki Olavi
Last Name:Linnosmaa
Suffix:
RePEc Short-ID:pli751
[This author has chosen not to make the email address public]

Affiliation

Sosiaali- ja terveyspolitiikan ja -talouden osasto
Terveyden ja Hyvinvoinnin Laitos (THL)

Helsinki, Finland
http://www.thl.fi/fi_FI/web/fi/organisaatio/rakenne/osastot/sosiaali_ja_terveyspolitiikka_ja_talous
RePEc:edi:stthlfi (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters

Working papers

  1. Hokkanen, Joni & Kangasharju, Aki & Linnosmaa, Ismo & Valtonen, Hannu, 2012. "Generic substitution policy, prices and market structure: evidence from a quasi-experiment in Finland," Working Papers 35, VATT Institute for Economic Research.
  2. Kulvik, Martti & Linnosmaa, Ismo & Hermans, Raine, 2006. "Adaption of New Technologies and Costs of Health Care," Discussion Papers 1037, The Research Institute of the Finnish Economy.
  3. Hermans, Raine & Linnosmaa, Ismo, 2003. "Price Markups and R&D Inputs: The Pharmaceutical Industry in Finland and the USA," Discussion Papers 877, The Research Institute of the Finnish Economy.
  4. Linnosmaa, Ismo & Hermans, Raine & Kauhanen, Taru, 2002. "Price-Cost Margin in the Pharmaneutical Industry: Empirical Evidence from Finland," Discussion Papers 818, The Research Institute of the Finnish Economy.

Articles

  1. Kankaanpää, Eila & Linnosmaa, Ismo & Valtonen, Hannu, 2013. "Market competition, ownership, payment systems and the performance of health care providers – a panel study among Finnish occupational health services providers," Health Economics, Policy and Law, Cambridge University Press, vol. 8(4), pages 477-510, October.
  2. Eila Kankaanpää & Ismo Linnosmaa & Hannu Valtonen, 2011. "Public health care providers and market competition: the case of Finnish occupational health services," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(1), pages 3-16, February.
  3. Linnosmaa Ismo Erkki, 2008. "Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 8(2), pages 1-37, July.
  4. Martikainen, Jaana & Kivi, Ismo & Linnosmaa, Ismo, 2005. "European prices of newly launched reimbursable pharmaceuticals - a pilot study," Health Policy, Elsevier, vol. 74(3), pages 235-246, November.
  5. Ismo Linnosmaa & Raine Hermans & Taru Hallinen, 2004. "Price-cost margin in the pharmaceutical industry," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(2), pages 122-128, May.

Chapters

  1. Sintonen, Harri & Linnosmaa, Ismo, 2000. "Economics of dental services," Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 24, pages 1251-1296, Elsevier.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Hokkanen, Joni & Kangasharju, Aki & Linnosmaa, Ismo & Valtonen, Hannu, 2012. "Generic substitution policy, prices and market structure: evidence from a quasi-experiment in Finland," Working Papers 35, VATT Institute for Economic Research.

    Cited by:

    1. Izhak, Olena, 2019. "Extra costs of integrity: Pharmacy markups and generic substitution in Finland," DICE Discussion Papers 307, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).

  2. Hermans, Raine & Linnosmaa, Ismo, 2003. "Price Markups and R&D Inputs: The Pharmaceutical Industry in Finland and the USA," Discussion Papers 877, The Research Institute of the Finnish Economy.

    Cited by:

    1. Hermans, Raine, . "International Mega-Trends and Growth Prospects of the Finnish Bio-technology Industry - Essays on New Economic Geography, Market Structure of the Pharmaceutical Industry, Sources of Financing, Intelle," ETLA A, The Research Institute of the Finnish Economy, number 40, June.

  3. Linnosmaa, Ismo & Hermans, Raine & Kauhanen, Taru, 2002. "Price-Cost Margin in the Pharmaneutical Industry: Empirical Evidence from Finland," Discussion Papers 818, The Research Institute of the Finnish Economy.

    Cited by:

    1. Tahvanainen, Antti-Jussi, 2004. "Academic Spin-offs in Finnish Biotechnology," Discussion Papers 900, The Research Institute of the Finnish Economy.
    2. Antti-Jussi Tahvanainen, 2004. "Growth Inhibitors Of Entrepreneurial Academic Spin-Offs: The Case Of Finnish Biotechnology," International Journal of Innovation and Technology Management (IJITM), World Scientific Publishing Co. Pte. Ltd., vol. 1(04), pages 455-475.

Articles

  1. Eila Kankaanpää & Ismo Linnosmaa & Hannu Valtonen, 2011. "Public health care providers and market competition: the case of Finnish occupational health services," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(1), pages 3-16, February.

    Cited by:

    1. Lin, Gui-Hua & Zhang, Dali & Liang, Yan-Chao, 2013. "Stochastic multiobjective problems with complementarity constraints and applications in healthcare management," European Journal of Operational Research, Elsevier, vol. 226(3), pages 461-470.

  2. Linnosmaa Ismo Erkki, 2008. "Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 8(2), pages 1-37, July.

    Cited by:

    1. de Frutos, Maria-Angeles & Ornaghi, Carmine & Siotis, Georges, 2013. "Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?," Journal of Health Economics, Elsevier, vol. 32(1), pages 268-285.

  3. Martikainen, Jaana & Kivi, Ismo & Linnosmaa, Ismo, 2005. "European prices of newly launched reimbursable pharmaceuticals - a pilot study," Health Policy, Elsevier, vol. 74(3), pages 235-246, November.

    Cited by:

    1. Garattini, Livio & Motterlini, Nicola & Cornago, Dante, 2008. "Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countries," Health Policy, Elsevier, vol. 85(3), pages 305-313, March.
    2. Costa-i-Font, Joan & Varol, Nebibe & McGuire, Alistair, 2011. "Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008," LSE Research Online Documents on Economics 37537, London School of Economics and Political Science, LSE Library.
    3. Aaltonen, Katri & Niemelä, Mikko & Norris, Pauline & Bell, J. Simon & Hartikainen, Sirpa, 2013. "Trends and income related differences in out-of-pocket costs for prescription and over-the-counter medicines in Finland from 1985 to 2006," Health Policy, Elsevier, vol. 110(2), pages 131-140.
    4. Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
    5. Lesley Tilson & Bernadette McGowan & Kathleen Bennett & Michael Barry, 2004. "The high cost of medicines in Ireland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(4), pages 341-344, November.

  4. Ismo Linnosmaa & Raine Hermans & Taru Hallinen, 2004. "Price-cost margin in the pharmaceutical industry," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(2), pages 122-128, May.

    Cited by:

    1. Hermans, Raine & Kauranen, Ilkka, 2003. "Intellectual Capital and Anticipated Future Sales in Small and Medium-sized Biotechnology Companies," Discussion Papers 856, The Research Institute of the Finnish Economy.
    2. Hermans, Raine & Linnosmaa, Ismo, 2003. "Price Markups and R&D Inputs: The Pharmaceutical Industry in Finland and the USA," Discussion Papers 877, The Research Institute of the Finnish Economy.
    3. Hermans, Raine, . "International Mega-Trends and Growth Prospects of the Finnish Bio-technology Industry - Essays on New Economic Geography, Market Structure of the Pharmaceutical Industry, Sources of Financing, Intelle," ETLA A, The Research Institute of the Finnish Economy, number 40, June.

Chapters

  1. Sintonen, Harri & Linnosmaa, Ismo, 2000. "Economics of dental services," Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 24, pages 1251-1296, Elsevier.

    Cited by:

    1. Ando Michihito & Takaku Reo, 2016. "Affordable False Teeth: The Effects of Patient Cost Sharing on Denture Utilization and Subjective Chewing Ability," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 16(3), pages 1387-1438, September.
    2. Nathan Kettlewell, 2019. "Utilization and Selection in an Ancillaries Health Insurance Market," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 86(4), pages 989-1017, December.
    3. Gutacker, Nils & Harris, Anthony & Brennan, David & Hollingsworth, Bruce, 2015. "The determinants of dentists' productivity and the measurement of output," Social Science & Medicine, Elsevier, vol. 124(C), pages 76-84.
    4. Martin Chalkley & Colin Tilley, 2005. "The Existence and Nature of Physician Agency: Evidence of Stinting from the British National Health Service," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 14(3), pages 647-664, September.
    5. Kreider, Brent & Moeller, John & Manski, Richard J. & Pepper, John, 2015. "The Effect of Dental Insurance on the Use of Dental Care for Older Adults: A Partial Identification Analysis," ISU General Staff Papers 201507010700001629, Iowa State University, Department of Economics.
    6. Jabłonowski, Janusz & Müller, Christoph, 2014. "A fiscal outlook for Poland: Update 2014. Background paper prepared for the World Bank's Country Economic Memorandum (CEM) for Poland," FZG Discussion Papers 54, University of Freiburg, Research Center for Generational Contracts (FZG).
    7. Michel Grignon & Jeremiah Hurley & Li Wang & Sara Allin, 2008. "Inequity in a market-based health system: evidence from Canada's dental sector," Centre for Health Economics and Policy Analysis Working Paper Series 2008-05, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.
    8. Lupi-Pegurier, Laurence & Clerc-Urmes, Isabelle & Abu-Zaineh, Mohammad & Paraponaris, Alain & Ventelou, Bruno, 2011. "Density of dental practitioners and access to dental care for the elderly: A multilevel analysis with a view on socio-economic inequality," Health Policy, Elsevier, vol. 103(2), pages 160-167.
    9. Shinya Sugawara & Yasuhiro Omori, 2013. "An Econometric Analysis of Insurance Markets with Separate Identification for Moral Hazard and Selection," CIRJE F-Series CIRJE-F-882, CIRJE, Faculty of Economics, University of Tokyo.
    10. Jaapar, Mustaffa & Musa, Ghazali & Moghavvemi, Sedigheh & Saub, Roslan, 2017. "Dental tourism: Examining tourist profiles, motivation and satisfaction," Tourism Management, Elsevier, vol. 61(C), pages 538-552.
    11. Kristensen, Nicolai & Andersen, Henrik Lindegaard, 2016. "Consumption Smoothing in the Demand for Health Care," IZA Discussion Papers 9655, Institute of Labor Economics (IZA).
    12. Elamin H. Elbasha & Mark L. Messonnier, 2004. "Cost‐effectiveness analysis and health care resource allocation: decision rules under variable returns to scale," Health Economics, John Wiley & Sons, Ltd., vol. 13(1), pages 21-35, January.
    13. Terance J. Rephann & Tanya Wanchek, 2012. "Filling the Gaps: Dentist Disparities along the Rural Urban Continuum," Working Papers 2012-02, Center for Economic and Policy Studies.
    14. Rephann, Terance J. & Wanchek, Tanya N., 2016. "Filling the Gaps: Explanations for Disparities in the Distribution of Dentists among U.S. Counties," Journal of Regional Analysis and Policy, Mid-Continent Regional Science Association, vol. 46(1).
    15. Shinya Sugawara & Yasuhiro Omori, 2012. "An Econometric Analysis of Insurance Markets with Separate Identification for Moral Hazard and Selection Problems," CIRJE F-Series CIRJE-F-849, CIRJE, Faculty of Economics, University of Tokyo.
    16. Anna-Lena Trescher & Stefan Listl & Onno Galien & Frank Gabel & Olivier Kalmus, 2020. "Once bitten, twice shy? Lessons learned from an experiment to liberalize price regulations for dental care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 425-436, April.
    17. Mazzanti, Giovanni Maria & Fiorentini, Gianluca, 2012. "Proposte per una revisione del finanziamento e dell’offerta dei servizi odontoiatrici in Italia. L’intervento pubblico e i fondi integrativi," AICCON Working Papers 100-2012, Associazione Italiana per la Cultura della Cooperazione e del Non Profit.
    18. Tanya Wanchek & Terance J. Rephann & William Shobe, 2011. "Oral Health and the Dental Care Workforce in Southwest Virginia," Reports 2011-03, Center for Economic and Policy Studies.
    19. UŢĂ, Cristian, 2011. "Reform In The Dental Services Area In Romania – Objective Necessity Or Second Option," Annals of Spiru Haret University, Economic Series, Universitatea Spiru Haret, vol. 2(3), pages 105-111.
    20. Lien Nguyen & Unto Häkkinen & Matti Knuuttila & Marjo‐Riitta Järvelin, 2008. "Should we brush twice a day? Determinants of dental health among young adults in Finland," Health Economics, John Wiley & Sons, Ltd., vol. 17(2), pages 267-286, February.
    21. Janusz Jabłonowski & Christoph Müller, 2014. "A fiscal outlook for Poland: Update 2014," NBP Working Papers 187, Narodowy Bank Polski.
    22. Gheorghe Raftu, 2016. "Dental Practice Management," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, vol. 0(2), pages 388-392, February.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 2 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-COM: Industrial Competition (1) 2012-09-16
  2. NEP-HEA: Health Economics (1) 2006-09-23
  3. NEP-IAS: Insurance Economics (1) 2006-09-23
  4. NEP-INO: Innovation (1) 2006-09-23
  5. NEP-IPR: Intellectual Property Rights (1) 2012-09-16

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Ismo Erkki Olavi Linnosmaa should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.